Capecitabine
Product Description
| Catalogue Number | C175650 |
| Chemical Name | Capecitabine |
| Synonyms | 5’-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine; [1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl] |
| CAS Number | 154361-50-9 |
| Molecular Formula | C₁₅H₂₂FN₃O₆ |
| Appearance | White to Off-White Solid |
| Melting Point | 119-121°C |
| Molecular Weight | 359.35 |
| Storage | -20°C |
| Solubility | Chloroform (Slightly), Methanol (Slightly) |
| Category | Standards; Pharmaceutical/API Drug Impurities/Metabolites; Carbohydrates and Oligosaccharides; |
| Applications | Capecitabine is an antineoplastic agent. Capecitabine is a prodrug of Doxifluridine (D556750). |
| References | Muss, H., et al.: New Eng. J. Med., 360, 2055 (2009), Takahashi, S., et al.: Drug Metab. Disposition, 37, 956 (2009), Saltz, L., et al.: J. Clin. Oncol., 27, 653 (2009), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009), |
